Neo-adjuvant Capecitabine Chemotherapy in Women with Newly Diagnosed Locally Advanced Breast Cancer in a Resource-poor Setting (Nigeria): Efficacy and Safety in a Phase II Feasibility Study

The majority of clinical trials of neo-adjuvant therapy for breast cancer have been conducted in resource-rich countries. We chose Nigeria, a resource-poor country, as the major site for a phase II feasibility open-label multicenter clinical trial designed to evaluate the efficacy, safety, and toler...

Descripción completa

Detalles Bibliográficos
Autores principales: Arowolo, Olukayode A, Njiaju, Uchenna O, Ogundiran, Temidayo O, Abidoye, Oyewale, Lawal, Olukayode O, Obajimi, Millicent, Adetiloye, Adebayo V, Im, Hae K, Akinkuolie, Akinbolaji A, Oluwasola, Abideen, Adelusola, Kayode, Kayode, Adesunkanmi A, Agbakwuru, Augustine E, Oduntan, Helen, Babalola, Chinedum P, Fleming, Gini, Olopade, Olusola C, Falusi, Adeyinka Gladys, Durosinmi, Muheez A, Olopade, Olufunmilayo I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282544/
https://www.ncbi.nlm.nih.gov/pubmed/23865786
http://dx.doi.org/10.1111/tbj.12149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282544/
https://www.ncbi.nlm.nih.gov/pubmed/23865786
http://dx.doi.org/10.1111/tbj.12149

Ejemplares similares